Contact number
+32 2 789 5000Provided by Chambers
Sullivan & Cromwell assists clients with EC merger filings made as part of multinational pharmaceutical or technology sector transactions, with particular experience in transactions connected to Germany, the US and South Korea. It also handles EU appeals against merger prohibitions and assists with the defence against EC investigations into anti-competitive conduct and in follow-on damages claims.
Provided by Sullivan & Cromwell LLP
Sullivan & Cromwell acted for Abiomed on its USD17.1 billion acquisition by Johnson & Johnson and subsequent merger clearances.
Provided by Chambers
"We got a law firm with high expertise, good connections and a good reputation."
"We got a law firm with high expertise, good connections and a good reputation."
Provided by Chambers
Michael Rosenthal heads the firm's competition team and leads sophisticated merger control and behavioural matters that involve interaction with the EC. Standout mandates include his defence of clients in EC behavioural investigations into alleged cartel activities and subsequent follow-on damages actions. Splitting his time between the firm's offices in Belgium and Germany, he also has notable experience assisting clients with notifying mergers before the German authorities.
"Michael Rosenthal has a lot of experience, knows his stuff and is good to work with."
"He is very thoughtful, you always feel like he is there for you. You feel like you are in safe hands with Michael on tricky issues and he has a wonderful demeanour in working with clients."
"He knows what he is doing, is very easy to deal with and gets the strategy. It was good to have someone of his experience and he is able to manage his clients well."